Carrick NewsroomPress Releases

Complia Health Appoints Rick Genovese As Executive Chairman

SCHAUMBURG, IL (JUNE 20, 2018)Complia Health, a leading global provider of technology for long-term and post-acute care, is pleased to announce the appointment of Rick Genovese as Executive Chairman effective July 1, 2018. Rick will replace the current executive, Chairman Mike Greenough, who will remain as the lead director as he transitions into retirement in late 2019.

Mr. Genovese is a seasoned C-Suite Executive with 35 years’ experience focused on the business and professional services and information technology market. Rick has an established track record of operating and financial management P&L performance skills focused on business and professional services, information technology, staffing and staff augmentation services, software, shared services and managed services/outsourcing. His past career includes leadership roles at Service Source and IBM as well as a partner at Price Waterhouse consulting, for many years.

“I thank Mike for his mentorship these last years and look forward to continuing our growth in the post-acute space with Rick,” said Chris Junker, President of Complia Health. “Rick brings a solid business acumen which will help steer the continued expansion of our SaaS and hosted offerings, given his deep experience in those areas. Rick has been advising and working with us periodically over this past year and I am looking forward to having his full attention.”

About Complia Health

Complia Health is a leading global provider of technology and expertise for the post-acute and long-term care markets. Nearly 3,000 home health, hospice, palliative care, residential care and community care organizations count on Complia Health for the clinical, operational, and financial solutions required to profitability deliver quality care to its clients. Complia Health’s innovative products—including Procura, ContinuLink, Suncoast, Igea, and Progresa—are supported by a team of global health and technology experts located in the United States, Canada, and Australia. For more information, visit http://www.compliahealth.com.

About Carrick Capital Partners
Who We Are
A firm of enterprise software and technology enabled services investors and operating executives with substantial experience founding, scaling, and optimizing market leading businesses.
Our Approach
We work with management to identify and improve critical areas of their business - focusing on the priorities that align with our experiences and that will deliver the highest strategic impact in both the short-term and long-run.
Why We Are Different
We have a concentrated number of companies in our portfolio so that we can build substantial relationships with each management team and ensure our firm's commitment to each company's goals.
Latest News
Accolade Logo.jpg
Global Technology Company Apptio Modernizes and Simplifies their Employee Healthcare and Benefits Experience by Bringing Accolade Connect to its Employees and their Family Members
February 20, 2019
Saama Logo
Campbell, CA (February 19, 2019) - Saama Technologies, Inc., a leading data analytics company, today unveiled three new, machine learning-based capabilities that extend the existing functionality of its award-winning Life Science Analytics Cloud (LSAC). Saama announced the addition of these state-of-the-art programs infused with artificial intelligence (AI) -- Virtual Assistant/AI, Operational and Financial Risk Mitigation, and Drug Efficacy and Patient Safety Analytics -- during the 10th Annual Summit for Clinical Ops Executives (SCOPE) in Orlando.
February 19, 2019
Axiom Logo.jpg
New York, NY (February 19, 2019) - Axiom Global Inc. today announced it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed offering is subject to, among other things, completion of the SEC review process and market conditions.
February 19, 2019